The effect of combined treatment with phenformin and stanazolol on blood lipids and fibrinolytic activity in patients with hypertriglyceridaemia

References

1. • Glueck C.J.
   • Levy R.I.
   • Fredrickson D.S.
   Immunoreactive insulin, glucose tolerance and carbohydrate inducibility in types II, III, IV and V hyperlipoproteinemia.
   J. Amer. Diab. Ass. 1969; 18: 739
   • PubMed
   • Google Scholar
2. • Ciświcka-Sznajderman M.
   Badania nad pierwotnymi hiperlipoproteidemiami.
   Pol. Arch. Med. Wewn. 1971; 46: 577
   • PubMed
   • Google Scholar
3. • Spöttl F.
   • Holzknecht F.
   • Knapp E.
   • Steinmetz U.
   • Braunsteiner H.
   A basic study of the global coagulation and fibrinolysis of hyperlipemic and atherosclerotic patients.
   Atherosclerosis. 1970; 12: 427
   • Scopus (15)
   • PubMed
   • Abstract
   • Full Text PDF
   • Google Scholar
4. • Holzknecht F.
   • Spöttl F.
   • Knapp E.
   • Steinmetz U.
   • Braunsteiner H.
   A basic study of the global coagulation and fibrinolysis of hyperlipemic and atherosclerotic patients.
   Atherosclerosis. 1970; 12: 415
   • Scopus (8)
   • PubMed
   • Abstract
   • Full Text PDF
   • Google Scholar
5. • Fearnley G.R.
   • Chakrabarti R.
   • Evans J.F.
   Fibrinolytic and defibrinating effect of phenformin plus ethyloestrenol in vivo.
   Lancet. 1969; i: 910
   • Abstract
   • Google Scholar
6. • Fearnley G.R.
   • Chakrabarti R.
   • Evans J.F.
   Effect of ethyloestrenol combined with phenformin or with metformin on platelet stickiness and serum-cholesterol in patients with occlusive vascular disease.
   Lancet. 1968; ii: 1004
   • Abstract
   • Google Scholar
7. • Isacson S.
   • Nilsson I.M.
   Effect of treatment with combined phenformin and ethyloestrenol on the coagulation and fibrinolytic system.
   Scand. J. Haematol. 1970; 7: 404
   • Scopus (40)
   • PubMed
   • Crossref
   • Google Scholar
8. • Tzagournis M.
   • Seidensticker J.F.
   • Hamwi G.J.
   Metabolic abnormalities in premature coronary disease, effects of therapy.
   Ann. N. Y. Acad. Sci. 1968; 148: 945
   • Scopus (11)
   • PubMed
   • Crossref
   • Google Scholar
9. • Boshell B.R.
   • Chandalia H.B.
   • McAdams G.L.
   • Roddam R.F.
   Phenformin and insulin secretion.
   Post. Med. J. 1969; (Suppl. May): 38
   • PubMed
   • Google Scholar
10. • Harsant P.R.
    A review of the mode of action of phenformin.
    Post. Med. J. 1969; (Suppl. May): 20
    • PubMed
    • Google Scholar
11. • Kuo P.T.
    • Quick R.E.
    Improvement of hypertriglyceridemia by anabolic agent in primary type I hyperlipoproteinemia.
    Circulation. 1970; 42: 66
    • Google Scholar
12. • Sperry W.M.
    • Webb M.
    A revision of the Schoenheimer-Sperry method for cholesterol determination.
    J. Biol. Chem. 1950; 187: 97
    • PubMed
    • Abstract
    • Full Text PDF
    • Google Scholar
13. • Ignatowska H.
    Bezporednia metoda oznaczania trójglicerydów w surowicy krwi.
    Pol. Arch. Med. Wewn. 1964; 34: 273
    • PubMed
    • Google Scholar
14. • Lees R.W.
    • Hatch F.T.
    Sharper separation of lipoprotein species by electrophoresis in albumin-containing buffer.
    J. Lab. Clin. Med. 1963; 61: 518
    • PubMed
    • Google Scholar
15. • Niewiarowski S.
    Krzepniecie krwi. 1960; (PZWL): 150
    • Google Scholar
16. • Fearnley G.R.
    • Balmforth G.
    • Fearnley E.
    Evidence of diurnal fibrinolytic rhythm.
    Clin. Sci. 1957; 16: 645
    • PubMed
    • Google Scholar
17. • Menon I.S.
    • Muscat-Baron J.
    • Weightman D.
    • Dewar H.A.
    The brain as contributor of plasminogen activator to the blood.
    Clin. Sci. 1970; 38: 85
    • PubMed
    • Google Scholar
18. • Grace C.S.
    • Goldrick R.B.
    Fibrinolysis and body build.
    J. Atheroscler. Res. 1968; 8: 705
    • Scopus (50)
    • PubMed
    • Abstract
    • Full Text PDF
    • Google Scholar
19. • Fearnley G.R.
    • Chakrabarti R.
    • Evans J.F.
    Mode of action of phenformin plus ethyloestrenol on fibrinolysis.
    Lancet. 1971; i: 723
    • Scopus (11)
    • Abstract
    • Google Scholar
20. • Epstein S.E.
    • Rosing D.R.
    • Brakman P.
    • Redwood D.R.
    • Astrup T.
    Impaired fibrinolytic response to exercise in patients with type IV hyperlipoproteinemia.
    Lancet. 1970; ii: 631
    • Scopus (51)
    • Abstract
    • Google Scholar
21. • Spöttl F.
    • Holzknecht F.
    • Braunsteiner H.
    Inhibitors of the plasminogen activation in patients with primary carbohydrate-induced hypertriglyceridemia.
    J. Atheroscler Res. 1968; 8: 821
    • Scopus (7)
    • PubMed
    • Abstract
    • Full Text PDF
    • Google Scholar
22. • Spöttl F.
    • Holzknecht F.
    • Braunsteiner H.
    Enhancement of the fibrinolytic activity by venous occlusion in patients with primary carbohydrate-induced hypertriglyceridemia.
    Acta Haematol. 1969; 41: 154
    • Scopus (5)
    • PubMed
    • Crossref
    • Google Scholar
23. • Chakrabarti R.
    • Hocking E.D.
    • Fearnley G.R.
    • Mann R.D.
    • Attwell T.N.
    • Jackson D.
    Fibrinolytic activity and coronary artery disease.
    Lancet. 1968; i: 987
    • Abstract
    • Google Scholar
24. • Ciświcka-Sznajderman M.
    • Młynski J.
    • Lotholc J.
    Czestość hiperlipoproteidemii u chorych z przebytym zawalem serca.
    Pol. Tyg. Lek. 1972; 2: 1673
    • Google Scholar
25. • Heinle R.A.
    • Levy R.J.
    • Fredrickson D.S.
    • Gorlick R.
    Lipid and carbohydrate abnormalities in patients with angiographically documented coronary artery disease.
    Amer. J. Cardiol. 1969; 24: 178
    • Scopus (137)
    • PubMed
    • Abstract
    • Full Text PDF
    • Google Scholar
26. • Skrzydlewski Z.
    • Niewiarowski S.
    Influence of plasma lipoproteins on the fibrinolytic activity.
    Thromb. Diath. Haemorrh. 1967; 17: 482
    • PubMed
    • Google Scholar